New

Global ETF Survey 2026 Available: How 620 Professionals Select ETFs. Access the Report →

Help us improve your experience. Please confirm your investor type:

Global ETF Survey 2026

Trackinsight Global ETF Survey 2026
›ETF Issuers›Invesco›WDHE
WDHE

Invesco S&P World Health Care ESG UCITS ETF

The WDHE Exchange Traded Fund (ETF) is provided by Invesco. It is built to track an index: S&P World ESG Enhanced Health Care Index. The WDHE ETF provides physical exposure, so by buying it you actually own parts of all the 64 underlying holdings. The dividend policy is capitalization.

Advertisement

Advertisement

$7.66
+$0.034 (+0.44%) yesterday
8:00 AM 11/03/26 Closed
1D price range
$7.63$7.67
52W price range
$5.96$7.72
YTD Perf.
+16.47%
YTD Flows
Annualized volatility
Fund AuM
€12M
Share class AuM
€12M
TTM Yield
-
Tracking Error
Tracking Difference
ISIN
IE000L4EH2K5
TER
0.18%
Inception date
4/12/2023
Issuer
Replication method
Dividend policy
Compare similar ETFs
API
PerformanceDec 31, 2025 - Nov 2, 2026
-10%-5%0%5%10%15%JANMARMAYJULSEPNOV
Flows
Join for free to unlock
Data as of 09/30/26
Healthcare
98.39%
Unavailable
0.61%
Other
1.00%
Latest WDHE news

No content available for this fund

FAQ about WDHE

WDHE is a passively managed ETF that invests in the World Health Care segment.
WDHE tracks the S&P World ESG Enhanced Health Care Index - USD, through a full replication replication method.
WDHE carries a total expense ratio (TER) of 0.18%.
WDHE was introduced to the market on April 12, 2023.
Invesco S&P World Health Care ESG UCITS ETF, WDHE, is provided by Invesco. Learn more about Invesco here.
WDHE oversees €12M in assets as of November 2, 2026.
WDHE follows a capitalizing, meaning it reinvests income within the fund.
As of September 30, 2026, WDHE has significant geographic allocations in USA, Switzerland and United Kingdom.
As of September 30, 2026, WDHE focuses largely on Healthcare.
As of September 30, 2026, WDHE holds 64 positions in its portfolio, with 77.59% of assets concentrated in its top 15 holdings.
As of September 30, 2026, WDHE top three holdings include Eli Lilly & Co., AbbVie, Inc. and Merck & Co., Inc..
The base currency of WDHE is USD.
Data as of 09/30/26
Eli Lilly & Co.
16.86%
AbbVie, Inc.
11.98%
Merck & Co., Inc.
7.50%
AstraZeneca PLC
4.74%
Gilead Sciences, Inc.
4.65%
Novartis AG
4.45%
Roche Holding AG
4.38%
Amgen, Inc.
4.06%
Thermo Fisher Scientific, Inc.
3.79%
Abbott Laboratories
3.66%

Trackinsight
Essentials

A forever free toolbox for fund selection, analysis, research, and ETF portfolio construction.

Essential free account includes:
  • More fund data
  • Compare up to 3 funds
  • More screener filters
  • Edit screener columns from 100+ metrics
  • Watchlists for saving your research
  • Portfolio construction and analysis
  • Personal dashboard for live monitoring
Trackinsight Global ETF Survey 2026: ETFs' Next Act: From Access to Selection. Access the report

Advertisement

Trackinsight

About Trackinsight

Since our founding in 2016, we have been at the forefront of the industry, delivering accessible, comprehensive, and reliable tools to support the evolving needs of investors.

Over the past decade, Trackinsight has expanded its operations across six countries, serving thousands of professional investors. We’ve consistently innovated to provide cutting-edge solutions that meet the changing demands of the ETF market.

In 2024, Kepler Cheuvreux, a leading independent European financial services firm, acquired a majority stake in Trackinsight, becoming the company's principal shareholder.

This strategic partnership solidifies Trackinsight's position as a premier provider of ETF selection and analysis tools, while strengthening Kepler Cheuvreux’s commitment to becoming a leading player in the ETF sector.

Together, we are committed to offering advanced services that empower professional investors, advisors, institutions, and issuers. This new step enables us to deliver even more comprehensive and innovative technological solutions, driving ETF investing to new heights.

More about Trackinsight
© 2014-2026 Trackinsight SA. All rights reserved.
Privacy policy  |  Cookie policy  |    |  Terms of use  |  Imprint
Trackinsight